Racially Disparate Expression of mTOR/ERK-1/2 Allied Proteins in Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Racially Disparate Expression of mTOR/ERK-1/2 Allied Proteins in Cancer
Authors
Keywords
-
Journal
Frontiers in Cell and Developmental Biology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-30
DOI
10.3389/fcell.2021.601929
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biological Aspects of Cancer Health Disparities
- (2021) Jennifer A. Freedman et al. Annual Review of Medicine
- Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression
- (2021) S. Mazher Hussain et al. CELLULAR ONCOLOGY
- Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
- (2020) Shannon Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TGF-beta: a master immune regulator
- (2020) Christopher Larson et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma
- (2020) Liangsong Zhu et al. Cell Death & Disease
- mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
- (2020) Zhilin Zou et al. Cell and Bioscience
- Cancer health disparities in racial/ethnic minorities in the United States
- (2020) Valentina A. Zavala et al. BRITISH JOURNAL OF CANCER
- Molecular and Cellular Factors Associated with Racial Disparity in Breast Cancer
- (2020) Manish Charan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- KRAS G12V mutation upregulates PD‐L1 expression via TGF‐β/EMT signaling pathway in human non‐small‐cell lung cancer
- (2020) Li‐Na Pan et al. CELL BIOLOGY INTERNATIONAL
- RDM1 promotes neuroblastoma growth through the RAS-Raf-MEK-ERK pathway
- (2019) Guojin Xie et al. FEBS Open Bio
- Phospho-ERK levels as predictors for chemotherapy of rectal carcinoma
- (2019) Susanne Holck et al. Oncotarget
- ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
- (2019) Iris C. Salaroglio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Analysis of the role of the Hippo pathway in cancer
- (2019) Yanyan Han Journal of Translational Medicine
- Blockade of TGF-β signaling: a potential target for cancer immunotherapy?
- (2019) Hendrik Ungefroren EXPERT OPINION ON THERAPEUTIC TARGETS
- GD2‐directed CAR‐T cells in combination with HGF‐targeted neutralizing antibody (AMG102) prevent primary tumor growth and metastasis in Ewing sarcoma
- (2019) Manish Charan et al. INTERNATIONAL JOURNAL OF CANCER
- ΔNp73/ETS2 complex drives glioblastoma pathogenesis— targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma
- (2019) Maren Cam et al. NEURO-ONCOLOGY
- Blocking TGF-β Signaling To Enhance The Efficacy Of Immune Checkpoint Inhibitor
- (2019) Xianguang Bai et al. OncoTargets and Therapy
- A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
- (2019) Braicu et al. Cancers
- Racial Disparities in the Molecular Landscape of Cancer
- (2018) ANTICANCER RESEARCH
- ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer
- (2018) Antonia K. Roseweir et al. BRITISH JOURNAL OF CANCER
- Ethnic differences in TGFβ-signaling pathway may contribute to prostate cancer health disparity
- (2018) Bethtrice Elliott et al. CARCINOGENESIS
- TGF-β Inhibition and Immunotherapy: Checkmate
- (2018) Karuna Ganesh et al. IMMUNITY
- Targeting EGFR-mediated autophagy as a potential strategy for cancer therapy
- (2018) Mopa Alina Sooro et al. INTERNATIONAL JOURNAL OF CANCER
- Downregulations of AKT/mTOR Signaling Pathway for Salmonella-Mediated Suppression of Matrix Metalloproteinases-9 Expression in Mouse Tumor Models
- (2018) Yu-Tzu Tsao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
- (2018) Daniele V. F. Tauriello et al. NATURE
- Genomic analysis of racial differences in triple negative breast cancer
- (2018) Chang-Sheng Chang et al. GENOMICS
- mTOR as a central hub of nutrient signalling and cell growth
- (2018) Joungmok Kim et al. NATURE CELL BIOLOGY
- Prevalence and Prognostic Significance of PTEN Loss in African-American and European-American Men Undergoing Radical Prostatectomy
- (2017) Jeffrey J. Tosoian et al. EUROPEAN UROLOGY
- Transforming Growth Factor β Superfamily Signaling in Development of Colorectal Cancer
- (2017) Barbara Jung et al. GASTROENTEROLOGY
- Silencing of TGF-β1 in tumor cells impacts MMP-9 in tumor microenvironment
- (2017) Lakisha D. Moore-Smith et al. Scientific Reports
- Increased Frequency of KRAS Mutations in African Americans Compared with Caucasians in Sporadic Colorectal Cancer
- (2017) Jonas J Staudacher et al. Clinical and Translational Gastroenterology
- mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells
- (2016) L. Josse et al. BIOCHEMICAL JOURNAL
- Genetic variations in the Hippo signaling pathway and breast cancer risk in African American women in the AMBER Consortium
- (2016) Jianmin Zhang et al. CARCINOGENESIS
- The Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and Aging
- (2016) Brian K. Kennedy et al. Cell Metabolism
- Suppression of MMP-9 and FAK expression by pomolic acid via blocking of NF-κB/ERK/mTOR signaling pathways in growth factor-stimulated human breast cancer cells
- (2016) Ji-Hyun Park et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population
- (2016) Carmela Ciccarelli et al. Molecular Cancer
- mTORC1 and mTORC2 in cancer and the tumor microenvironment
- (2016) L C Kim et al. ONCOGENE
- Targeting the KRAS Pathway in Non-Small Cell Lung Cancer
- (2016) P. Tomasini et al. ONCOLOGIST
- Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell Carcinoma
- (2016) Bhavani Krishnan et al. JAMA Oncology
- Genetic variants in the mTOR pathway and breast cancer risk in African American women
- (2015) Ting-Yuan David Cheng et al. CARCINOGENESIS
- Activation of matrix metalloproteinase-9 (MMP-9) by neurotensin promotes cell invasion and migration through ERK pathway in gastric cancer
- (2015) Hafeza Akter et al. TUMOR BIOLOGY
- Chrysin Inhibits Tumor Promoter-Induced MMP-9 Expression by Blocking AP-1 via Suppression of ERK and JNK Pathways in Gastric Cancer Cells
- (2015) Yong Xia et al. PLoS One
- ERKs in Cancer: Friends or Foes?
- (2014) Xavier Deschênes-Simard et al. CANCER RESEARCH
- Metabolic Regulation by p53 Family Members
- (2013) Celia R. Berkers et al. Cell Metabolism
- Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry
- (2013) Lei Quan et al. INTERNATIONAL JOURNAL OF CANCER
- mTOR Inhibitors Control the Growth of EGFR Mutant Lung Cancer Even after Acquiring Resistance by HGF
- (2013) Daisuke Ishikawa et al. PLoS One
- The Role of Mechanistic Target of Rapamycin (mTOR) Complexes Signaling in the Immune Responses
- (2013) Ghada Soliman Nutrients
- Targeting the PI3K-AKT-mTOR signaling network in cancer
- (2013) Khurum H. Khan et al. Chinese Journal of Cancer
- Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
- (2012) Shile Huang et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- High ERK Protein Expression Levels Correlate with Shorter Survival in Triple-Negative Breast Cancer Patients
- (2012) C. Bartholomeusz et al. ONCOLOGIST
- Mammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year Update
- (2012) John M. Kyriakis et al. PHYSIOLOGICAL REVIEWS
- Racial Differences and Disparities in Cancer Care and Outcomes
- (2012) Nestor F. Esnaola et al. Surgical Oncology Clinics of North America
- MAP Kinase Pathways
- (2012) D. K. Morrison Cold Spring Harbor Perspectives in Biology
- mTOR Inhibitors in Advanced Renal Cell Carcinoma
- (2011) Martin H. Voss et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
- (2011) Michelle C. Mendoza et al. TRENDS IN BIOCHEMICAL SCIENCES
- p53-family proteins and their regulators: hubs and spokes in tumor suppression
- (2010) L Collavin et al. CELL DEATH AND DIFFERENTIATION
- Emergence of the Phosphoinositide 3-Kinase-Akt- Mammalian Target of Rapamycin Axis in Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition
- (2010) Samy Lamouille et al. CELLS TISSUES ORGANS
- Regulation of transforming growth factor-β1 by insulin in prediabetic African Americans
- (2010) Yonghong Huan et al. KIDNEY INTERNATIONAL
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9
- (2009) Jing-song Chen et al. HEPATOLOGY RESEARCH
- Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men
- (2009) Dritschilo INTERNATIONAL JOURNAL OF ONCOLOGY
- Racial disparities in cancer therapy
- (2008) Cary P. Gross et al. CANCER
- A Gene Signature-Based Approach Identifies mTOR as a Regulator of p73
- (2008) J. M. Rosenbluth et al. MOLECULAR AND CELLULAR BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now